RQ Bio
Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients
$115MSeries A
Role not disclosedFL
Frazier Life Sciences
Activity from announced rounds
Activity in this selectionUnited Kingdom
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $115M 1 disclosed · full round size, not this investor’s share